Cited by 174

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

The central moTOR of metabolism

Simcox, Judith, Lamming, Dudley W.·2022·Developmental Cell

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.devcel.2022.02.024

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 41 references

Research works printed but not linked: 180

  1. Altschuler, 2021, Rapamycin added to diet in late mid-life delays age-related hearing loss in UMHET4 mice, Front. Cell. Neurosci., 15, 658972, 10.3389/fncel.2021.658972 · DOI
  2. An, 2020, Rapamycin rejuvenates oral health in aging mice, Elife, 9, e54318, 10.7554/eLife.54318 · DOI
  3. Arias, 2015, Lysosomal mTORC2/PHLPP1/Akt regulate chaperone-mediated autophagy, Mol. Cell, 59, 270, 10.1016/j.molcel.2015.05.030 · DOI
  4. Arif, 2017, EPRS is a critical mTORC1-S6K1 effector that influences adiposity in mice, Nature, 542, 357, 10.1038/nature21380 · DOI · Paper page
  5. Arriola Apelo, 2016, mTORC2 puts its shoulder to Krebs' wheel, Mol. Cell, 63, 723, 10.1016/j.molcel.2016.08.016 · DOI
  6. Arriola Apelo, 2020, Ovariectomy uncouples lifespan from metabolic health and reveals a sex-hormone-dependent role of hepatic mTORC2 in aging, Elife, 9, e56177, 10.7554/eLife.56177 · DOI · Paper page
  7. Arriola Apelo, 2016, Intermittent administration of rapamycin extends the life span of female C57BL/6J mice, J. Gerontol. A Biol. Sci. Med. Sci., 71, 876, 10.1093/gerona/glw064 · DOI
  8. Baar, 2016, Sex- and tissue-specific changes in mTOR signaling with age in C57BL/6J mice, Aging Cell, 15, 155, 10.1111/acel.12425 · DOI · Paper page
  9. Bar-Peled, 2013, A Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1, Science, 340, 1100, 10.1126/science.1232044 · DOI · Paper page
  10. Ben-Sahra, 2013, Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1, Science, 339, 1323, 10.1126/science.1228792 · DOI · Paper page
  11. Berchtold, 2012, Plasma membrane stress induces relocalization of Slm proteins and activation of TORC2 to promote sphingolipid synthesis, Nat. Cell Biol., 14, 542, 10.1038/ncb2480 · DOI
  12. Berchtold, 2009, TORC2 plasma membrane localization is essential for cell viability and restricted to a distinct domain, Mol. Biol. Cell, 20, 1565, 10.1091/mbc.e08-10-1001 · DOI
  13. Betz, 2013, Feature article: mTOR complex 2-Akt signaling at mitochondria-associated endoplasmic reticulum membranes (MAM) regulates mitochondrial physiology, Proc. Natl. Acad. Sci. USA, 110, 12526, 10.1073/pnas.1302455110 · DOI · Paper page
  14. Bitto, 2016, Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice, Elife, 5, e16351, 10.7554/eLife.16351 · DOI · Paper page
  15. Blagosklonny, 2012, Once again on rapamycin-induced insulin resistance and longevity: despite of or owing to, Aging (Albany NY), 4, 350, 10.18632/aging.100461 · DOI
  16. Brown, 1994, A mammalian protein targeted by G1-arresting rapamycin-receptor complex, Nature, 369, 756, 10.1038/369756a0 · DOI · Paper page
  17. Buj, 2019, Suppression of p16 induces mTORC1-mediated nucleotide metabolic reprogramming, Cell Rep., 28, 1971, 10.1016/j.celrep.2019.07.084 · DOI
  18. Cao, 2011, Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells, Sci. Transl. Med., 3, 89ra58, 10.1126/scitranslmed.3002346 · DOI · Paper page
  19. Castro, 2021, Adipocyte-specific mTORC2 deficiency impairs BAT and iWAT thermogenic capacity without affecting glucose uptake and energy expenditure in cold-acclimated mice, Am. J. Physiol. Endocrinol. Metab., 321, E592, 10.1152/ajpendo.00587.2020 · DOI
  20. Chang, 2020, TGFB-INHB/activin signaling regulates age-dependent autophagy and cardiac health through inhibition of MTORC2, Autophagy, 16, 1807, 10.1080/15548627.2019.1704117 · DOI · Paper page
  21. Chantranupong, 2014, The Sestrins interact with GATOR2 to negatively regulate the amino-acid-sensing pathway upstream of mTORC1, Cell Rep., 9, 1, 10.1016/j.celrep.2014.09.014 · DOI · Paper page
  22. Chellappa, 2019, Hypothalamic mTORC2 is essential for metabolic health and longevity, Aging Cell, 18, e13014, 10.1111/acel.13014 · DOI · Paper page
  23. Chen, 2009, mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells, Sci. Signal., 2, ra75, 10.1126/scisignal.2000559 · DOI · Paper page
  24. Cho, 2021, mTORC1 promotes cell growth via m(6)A-dependent mRNA degradation, Mol. Cell, 81, 2064, 10.1016/j.molcel.2021.03.010 · DOI
  25. Choi, 2016, The underlying mechanism of proinflammatory NF-kappaB activation by the mTORC2/Akt/IKKalpha pathway during skin aging, Oncotarget, 7, 52685, 10.18632/oncotarget.10943 · DOI
  26. Chung, 2019, Covalent targeting of the vacuolar H(+)-ATPase activates autophagy via mTORC1 inhibition, Nat. Chem. Biol., 15, 776, 10.1038/s41589-019-0308-4 · DOI
  27. Condon, 2021, Genome-wide CRISPR screens reveal multitiered mechanisms through which mTORC1 senses mitochondrial dysfunction, Proc. Natl. Acad. Sci. USA, 118, 10.1073/pnas.2022120118 · DOI · Paper page
  28. Corradetti, 2004, Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome, Genes Dev., 18, 1533, 10.1101/gad.1199104 · DOI
  29. Cunningham, 2007, mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex, Nature, 450, 736, 10.1038/nature06322 · DOI · Paper page
  30. Cybulski, 2009, mTOR complex 2 in adipose tissue negatively controls whole-body growth, Proc. Natl. Acad. Sci. USA, 106, 9902, 10.1073/pnas.0811321106 · DOI
  31. Dai, 2014, Altered proteome turnover and remodeling by short-term caloric restriction or rapamycin rejuvenate the aging heart, Aging Cell, 13, 529, 10.1111/acel.12203 · DOI
  32. de la Calle Arregui, 2021, Limited survival and impaired hepatic fasting metabolism in mice with constitutive Rag GTPase signaling, Nat. Commun., 12, 3660, 10.1038/s41467-021-23857-8 · DOI
  33. Demetriades, 2014, Regulation of TORC1 in response to amino acid starvation via lysosomal recruitment of TSC2, Cell, 156, 786, 10.1016/j.cell.2014.01.024 · DOI
  34. Dibble, 2012, TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1, Mol. Cell, 47, 535, 10.1016/j.molcel.2012.06.009 · DOI · Paper page
  35. Dibble, 2013, Signal integration by mTORC1 coordinates nutrient input with biosynthetic output, Nat. Cell Biol., 15, 555, 10.1038/ncb2763 · DOI
  36. Dominick, 2015, Regulation of mTOR activity in Snell dwarf and GH receptor gene-disrupted mice, Endocrinology, 156, 565, 10.1210/en.2014-1690 · DOI · Paper page
  37. Dong, 2020, Insulin-induced de novo lipid synthesis occurs mainly via mTOR-dependent regulation of proteostasis of SREBP-1c, Mol. Cell. Biochem., 463, 13, 10.1007/s11010-019-03625-5 · DOI
  38. Dumas, 2020, Next generation strategies for Geroprotection via mTORC1 inhibition, J. Gerontol. A Biol. Sci. Med. Sci., 75, 14, 10.1093/gerona/glz056 · DOI
  39. Düvel, 2010, Activation of a metabolic gene regulatory network downstream of mTOR complex 1, Mol. Cell, 39, 171, 10.1016/j.molcel.2010.06.022 · DOI · Paper page
  40. Ebner, 2017, Localization of mTORC2 activity inside cells, J. Cell Biol., 216, 343, 10.1083/jcb.201610060 · DOI
  41. Efeyan, 2013, Regulation of mTORC1 by the Rag GTPases is necessary for neonatal autophagy and survival, Nature, 493, 679, 10.1038/nature11745 · DOI
  42. Evert, 2012, V-AKT murine thymoma viral oncogene homolog/mammalian target of rapamycin activation induces a module of metabolic changes contributing to growth in insulin-induced hepatocarcinogenesis, Hepatology, 55, 1473, 10.1002/hep.25600 · DOI
  43. Fitzian, 2021, TSC1 binding to lysosomal PIPs is required for TSC complex translocation and mTORC1 regulation, Mol. Cell, 81, 2705, 10.1016/j.molcel.2021.04.019 · DOI
  44. Flynn, 2013, Late-life rapamycin treatment reverses age-related heart dysfunction, Aging Cell, 12, 851, 10.1111/acel.12109 · DOI
  45. Frias, 2006, mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s, Curr. Biol., 16, 1865, 10.1016/j.cub.2006.08.001 · DOI
  46. Fromm, 2020, Structural mechanism for amino acid-dependent Rag GTPase nucleotide state switching by SLC38A9, Nat. Struct. Mol. Biol., 27, 1017, 10.1038/s41594-020-0490-9 · DOI
  47. Garaeva, 2016, Mitochondrial dysfunction induces SESN2 gene expression through activating transcription factor 4, Cell Cycle, 15, 64, 10.1080/15384101.2015.1120929 · DOI
  48. Garratt, 2017, Sex differences in lifespan extension with acarbose and 17-alpha estradiol: gonadal hormones underlie male-specific improvements in glucose tolerance and mTORC2 signaling, Aging Cell, 16, 1256, 10.1111/acel.12656 · DOI · Paper page
  49. Gaubitz, 2015, Molecular basis of the rapamycin insensitivity of target of rapamycin complex 2, Mol. Cell, 58, 977, 10.1016/j.molcel.2015.04.031 · DOI · Paper page
  50. Ge, 2020, The role of the pentose phosphate pathway in diabetes and cancer, Front. Endocrinol., 11, 365, 10.3389/fendo.2020.00365 · DOI
  51. Gkountakos, 2018, Unmasking the impact of Rictor in cancer: novel insights of mTORC2 complex, Carcinogenesis, 39, 971, 10.1093/carcin/bgy086 · DOI
  52. Green, 2021, A food with medicine approach to health, Cell Metab., 33, 2303, 10.1016/j.cmet.2021.11.012 · DOI
  53. Green, 2021, We are more than what we eat, Nat. Metab., 3, 1144, 10.1038/s42255-021-00434-3 · DOI
  54. Green, 2022, Molecular mechanisms of dietary restriction promoting health and longevity, Nat. Rev. Mol. Cell Biol., 23, 56, 10.1038/s41580-021-00411-4 · DOI · Paper page
  55. Green, 2022, Sex and genetic background define the metabolic, physiologic, and molecular response to protein restriction, Cell Metab., 34, 209, 10.1016/j.cmet.2021.12.018 · DOI
  56. Gu, 2017, SAMTOR is an S-adenosylmethionine sensor for the mTORC1 pathway, Science, 358, 813, 10.1126/science.aao3265 · DOI
  57. Gu, 2017, mTORC2 regulates amino acid metabolism in cancer by phosphorylation of the cystine-glutamate antiporter xCT, Mol. Cell, 67, 128, 10.1016/j.molcel.2017.05.030 · DOI
  58. Gu, 2011, Rictor/mTORC2 is essential for maintaining a balance between beta-cell proliferation and cell size, Diabetes, 60, 827, 10.2337/db10-1194 · DOI
  59. Guertin, 2009, mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice, Cancer Cell, 15, 148, 10.1016/j.ccr.2008.12.017 · DOI · Paper page
  60. Haghighat, 1995, Repression of cap-dependent translation by 4E-binding protein 1: competition with p220 for binding to eukaryotic initiation factor-4E, EMBO J., 14, 5701, 10.1002/j.1460-2075.1995.tb00257.x · DOI
  61. Han, 2015, The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1, Nature, 524, 243, 10.1038/nature14557 · DOI
  62. Hannan, 2003, mTOR-dependent regulation of ribosomal gene transcription requires S6K1 and is mediated by phosphorylation of the carboxy-terminal activation domain of the nucleolar transcription factor UBF, Mol. Cell. Biol., 23, 8862, 10.1128/MCB.23.23.8862-8877.2003 · DOI
  63. Hansen, 2007, Lifespan extension by conditions that inhibit translation in Caenorhabditis elegans, Aging Cell, 6, 95, 10.1111/j.1474-9726.2006.00267.x · DOI · Paper page
  64. Hara, 2002, Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action, Cell, 110, 177, 10.1016/S0092-8674(02)00833-4 · DOI
  65. Harrington, 2004, The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins, J. Cell Biol., 166, 213, 10.1083/jcb.200403069 · DOI
  66. Hesketh, 2020, The GATOR-Rag GTPase pathway inhibits mTORC1 activation by lysosome-derived amino acids, Science, 370, 351, 10.1126/science.aaz0863 · DOI
  67. Holz, 2005, mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events, Cell, 123, 569, 10.1016/j.cell.2005.10.024 · DOI · Paper page
  68. Horvath, 2021, DNA methylation age analysis of rapamycin in common marmosets, GeroScience, 43, 2413, 10.1007/s11357-021-00438-7 · DOI
  69. Hoxhaj, 2017, The mTORC1 signaling network senses changes in cellular purine nucleotide levels, Cell Rep., 21, 1331, 10.1016/j.celrep.2017.10.029 · DOI
  70. Hsu, 2011, The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling, Science, 332, 1317, 10.1126/science.1199498 · DOI · Paper page
  71. Inoki, 2002, TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling, Nat. Cell Biol., 4, 648, 10.1038/ncb839 · DOI · Paper page
  72. Jeffery, 2014, Characterization of Cre recombinase models for the study of adipose tissue, Adipocyte, 3, 206, 10.4161/adip.29674 · DOI
  73. Jiang, 2015, Mice lacking neutral amino acid transporter B(0)AT1 (Slc6a19) have elevated levels of FGF21 and GLP-1 and improved glycaemic control, Mol. Metab., 4, 406, 10.1016/j.molmet.2015.02.003 · DOI
  74. Johnston, 2008, Sirolimus is associated with new-onset diabetes in kidney transplant recipients, J. Am. Soc. Nephrol., 19, 1411, 10.1681/ASN.2007111202 · DOI · Paper page
  75. Jones, 2017, MenTORing immunity: mTOR signaling in the development and function of tissue-resident immune cells, Immunity, 46, 730, 10.1016/j.immuni.2017.04.028 · DOI
  76. Joseph, 2019, Partial inhibition of mTORC1 in aged rats counteracts the decline in muscle mass and reverses molecular signaling associated with sarcopenia, Mol. Cell. Biol., 39, e00119, 10.1128/MCB.00141-19 · DOI · Paper page
  77. Julien, 2010, mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling, Mol. Cell. Biol., 30, 908, 10.1128/MCB.00601-09 · DOI
  78. Jung, 2019, Non-canonical mTORC2 signaling regulates brown adipocyte lipid catabolism through SIRT6-FoxO1, Mol. Cell, 75, 807, 10.1016/j.molcel.2019.07.023 · DOI
  79. Kaeberlein, 2005, Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients, Science, 310, 1193, 10.1126/science.1115535 · DOI · Paper page
  80. Kaizuka, 2010, Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly, J. Biol. Chem., 285, 20109, 10.1074/jbc.M110.121699 · DOI
  81. Kang, 2013, mTORC1 phosphorylation sites encode their sensitivity to starvation and rapamycin, Science, 341, 1236566, 10.1126/science.1236566 · DOI
  82. Kapahi, 2004, Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway, Curr. Biol., 14, 885, 10.1016/j.cub.2004.03.059 · DOI · Paper page
  83. Karuppasamy, 2017, Cryo-EM structure of Saccharomyces cerevisiae target of rapamycin complex 2, Nat. Commun., 8, 1729, 10.1038/s41467-017-01862-0 · DOI
  84. Karusheva, 2019, Short-term dietary reduction of branched-chain amino acids reduces meal-induced insulin secretion and modifies microbiome composition in type 2 diabetes: a randomized controlled crossover trial, Am. J. Clin. Nutr., 110, 1098, 10.1093/ajcn/nqz191 · DOI
  85. Kennedy, 2016, The mechanistic target of rapamycin: the grand ConducTOR of metabolism and aging, Cell Metab., 23, 990, 10.1016/j.cmet.2016.05.009 · DOI · Paper page
  86. Khanna, 2013, XPLN is an endogenous inhibitor of mTORC2, Proc. Natl. Acad. Sci. USA, 110, 15979, 10.1073/pnas.1310434110 · DOI
  87. Kim, 2002, mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery, Cell, 110, 163, 10.1016/S0092-8674(02)00808-5 · DOI
  88. Kim, 2003, GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR, Mol. Cell, 11, 895, 10.1016/S1097-2765(03)00114-X · DOI
  89. Kliegman, 2013, Chemical genetics of rapamycin-insensitive TORC2 in S. cerevisiae, Cell Rep., 5, 1725, 10.1016/j.celrep.2013.11.040 · DOI
  90. Kumar, 2008, Muscle-specific deletion of rictor impairs insulin-stimulated glucose transport and enhances Basal glycogen synthase activity, Mol. Cell. Biol., 28, 61, 10.1128/MCB.01405-07 · DOI
  91. Kumar, 2010, Fat cell-specific ablation of rictor in mice impairs insulin-regulated fat cell and whole-body glucose and lipid metabolism, Diabetes, 59, 1397, 10.2337/db09-1061 · DOI
  92. Lamming, 2014, Diminished mTOR signaling: a common mode of action for endocrine longevity factors, SpringerPlus, 3, 735, 10.1186/2193-1801-3-735 · DOI · Paper page
  93. Lamming, 2020, SAT-611 dietary reduction of branched-chain amino acids, J. Endocr. Soc., 4, A942
  94. Lamming, 2014, Depletion of Rictor, an essential protein component of mTORC2, decreases male lifespan, Aging Cell, 13, 911, 10.1111/acel.12256 · DOI · Paper page
  95. Lamming, 2012, Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity, Science, 335, 1638, 10.1126/science.1215135 · DOI · Paper page
  96. Lee, 2017, Post-transcriptional regulation of de novo lipogenesis by mTORC1-S6K1-SRPK2 signaling, Cell, 171, 1545, 10.1016/j.cell.2017.10.037 · DOI
  97. Lee, 2016, Raptor/mTORC1 loss in adipocytes causes progressive lipodystrophy and fatty liver disease, Mol. Metab., 5, 422, 10.1016/j.molmet.2016.04.001 · DOI
  98. Lees, 2014, Methionine restriction restores a younger metabolic phenotype in adult mice with alterations in fibroblast growth factor 21, Aging Cell, 13, 817, 10.1111/acel.12238 · DOI
  99. Liu, 2015, PtdIns(3,4,5)P3-dependent activation of the mTORC2 kinase complex, Cancer Discov., 5, 1194, 10.1158/2159-8290.CD-15-0460 · DOI
  100. Mahoney, 2018, A small molecule inhibitor of Rheb selectively targets mTORC1 signaling, Nat. Commun., 9, 548, 10.1038/s41467-018-03035-z · DOI · Paper page
  101. Manning, 2002, Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/Akt pathway, Mol. Cell, 10, 151, 10.1016/S1097-2765(02)00568-3 · DOI · Paper page
  102. Mauvoisin, 2007, Role of the PI3-kinase/mTor pathway in the regulation of the stearoyl CoA desaturase (SCD1) gene expression by insulin in liver, J. Cell Commun. Signal., 1, 113, 10.1007/s12079-007-0011-1 · DOI
  103. Mayer, 2004, mTOR-dependent activation of the transcription factor TIF-IA links rRNA synthesis to nutrient availability, Genes Dev., 18, 423, 10.1101/gad.285504 · DOI
  104. Menon, 2014, Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome, Cell, 156, 771, 10.1016/j.cell.2013.11.049 · DOI · Paper page
  105. Miller, 2014, Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction, Aging Cell, 13, 468, 10.1111/acel.12194 · DOI
  106. Mizunuma, 2014, mTORC2-SGK-1 acts in two environmentally responsive pathways with opposing effects on longevity, Aging Cell, 13, 869, 10.1111/acel.12248 · DOI · Paper page
  107. Moloughney, 2016, mTORC2 responds to glutamine catabolite levels to modulate the hexosamine biosynthesis enzyme GFAT1, Mol. Cell, 63, 811, 10.1016/j.molcel.2016.07.015 · DOI
  108. Mossmann, 2018, mTOR signalling and cellular metabolism are mutual determinants in cancer, Nat. Rev. Cancer, 18, 744, 10.1038/s41568-018-0074-8 · DOI · Paper page
  109. Nakashima, 2013, Association of CAD, a multifunctional protein involved in pyrimidine synthesis, with mLST8, a component of the mTOR complexes, J. Biomed. Sci., 20, 24, 10.1186/1423-0127-20-24 · DOI
  110. Nojima, 2013, Haploinsufficiency of akt1 prolongs the lifespan of mice, PLoS One, 8, e69178, 10.1371/journal.pone.0069178 · DOI
  111. Oh, 2010, mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide, EMBO J., 29, 3939, 10.1038/emboj.2010.271 · DOI
  112. Orozco, 2020, Dihydroxyacetone phosphate signals glucose availability to mTORC1, Nat. Metab., 2, 893, 10.1038/s42255-020-0250-5 · DOI · Paper page
  113. Pakos-Zebrucka, 2016, The integrated stress response, EMBO Rep., 17, 1374, 10.15252/embr.201642195 · DOI · Paper page
  114. Paolella, 2020, mTORC1 restrains adipocyte lipolysis to prevent systemic hyperlipidemia, Mol. Metab., 32, 136, 10.1016/j.molmet.2019.12.003 · DOI
  115. Park, 2017, mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4, Cell Rep., 19, 1083, 10.1016/j.celrep.2017.04.042 · DOI · Paper page
  116. Park, 2009, CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima, J. Clin. Invest., 119, 136
  117. Parmigiani, 2014, Sestrins inhibit mTORC1 kinase activation through the GATOR complex, Cell Rep., 9, 1281, 10.1016/j.celrep.2014.10.019 · DOI · Paper page
  118. Pause, 1994, Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5′-cap function, Nature, 371, 762, 10.1038/371762a0 · DOI
  119. Pearce, 2007, Identification of Protor as a novel Rictor-binding component of mTOR complex-2, Biochem. J., 405, 513, 10.1042/BJ20070540 · DOI
  120. Peng, 2002, The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation, Mol. Cell. Biol., 22, 5575, 10.1128/MCB.22.15.5575-5584.2002 · DOI
  121. Peterson, 2009, DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival, Cell, 137, 873, 10.1016/j.cell.2009.03.046 · DOI · Paper page
  122. Peterson, 2011, mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway, Cell, 146, 408, 10.1016/j.cell.2011.06.034 · DOI
  123. Porstmann, 2008, SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth, Cell Metab., 8, 224, 10.1016/j.cmet.2008.07.007 · DOI · Paper page
  124. Powers, 2006, Extension of chronological life span in yeast by decreased TOR pathway signaling, Genes Dev., 20, 174, 10.1101/gad.1381406 · DOI · Paper page
  125. Prakash, 2019, Ribosome biogenesis during cell cycle arrest fuels EMT in development and disease, Nat. Commun., 10, 2110, 10.1038/s41467-019-10100-8 · DOI
  126. Puente, 2016, Nutrient-regulated phosphorylation of ATG13 inhibits starvation-induced autophagy, J. Biol. Chem., 291, 6026, 10.1074/jbc.M115.689646 · DOI
  127. Pusapati, 2016, mTORC1-dependent metabolic reprogramming underlies escape from glycolysis addiction in cancer cells, Cancer Cell, 29, 548, 10.1016/j.ccell.2016.02.018 · DOI
  128. Quan, 2020, Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation, J. Exp. Clin. Cancer Res., 39, 266, 10.1186/s13046-020-01762-0 · DOI
  129. Rachdi, 2008, Disruption of Tsc2 in pancreatic beta cells induces beta cell mass expansion and improved glucose tolerance in a TORC1-dependent manner, Proc. Natl. Acad. Sci. USA, 105, 9250, 10.1073/pnas.0803047105 · DOI
  130. Raught, 2004, Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases, EMBO J., 23, 1761, 10.1038/sj.emboj.7600193 · DOI
  131. Richardson, 2021, Lifelong restriction of dietary branched-chain amino acids has sex-specific benefits for frailty and lifespan in mice, Nat. Aging, 1, 73, 10.1038/s43587-020-00006-2 · DOI · Paper page
  132. Riggi, 2018, Decrease in plasma membrane tension triggers PtdIns(4,5)P2 phase separation to inactivate TORC2, Nat. Cell Biol., 20, 1043, 10.1038/s41556-018-0150-z · DOI
  133. Robitaille, 2013, Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis, Science, 339, 1320, 10.1126/science.1228771 · DOI · Paper page
  134. Sabatini, 1994, RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs, Cell, 78, 35, 10.1016/0092-8674(94)90570-3 · DOI · Paper page
  135. Saha, 2014, Akt phosphorylation and regulation of transketolase is a nodal point for amino acid control of purine synthesis, Mol. Cell, 55, 264, 10.1016/j.molcel.2014.05.028 · DOI
  136. Sancak, 2008, The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1, Science, 320, 1496, 10.1126/science.1157535 · DOI · Paper page
  137. Sarbassov, 2004, Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton, Curr. Biol., 14, 1296, 10.1016/j.cub.2004.06.054 · DOI · Paper page
  138. Sarbassov, 2006, Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB, Mol. Cell, 22, 159, 10.1016/j.molcel.2006.03.029 · DOI · Paper page
  139. Saxton, 2016, Mechanism of arginine sensing by CASTOR1 upstream of mTORC1, Nature, 536, 229, 10.1038/nature19079 · DOI · Paper page
  140. Saxton, 2016, The apo-structure of the leucine sensor Sestrin2 is still elusive, Sci. Signal., 9, ra92, 10.1126/scisignal.aah4497 · DOI
  141. Scaiola, 2020, The 3.2-A resolution structure of human mTORC2, Sci. Adv., 6, eabc1251, 10.1126/sciadv.abc1251 · DOI · Paper page
  142. Schreiber, 2019, A novel rapamycin analog is highly selective for mTORC1 in vivo, Nat. Commun., 10, 3194, 10.1038/s41467-019-11174-0 · DOI · Paper page
  143. Seah, 2016, Autophagy-mediated longevity is modulated by lipoprotein biogenesis, Autophagy, 12, 261, 10.1080/15548627.2015.1127464 · DOI
  144. Seeley, 2021, Mice as experimental models for human physiology: when several degrees in housing temperature matter, Nat. Metab., 3, 443, 10.1038/s42255-021-00372-0 · DOI
  145. Sharp, 2005, Evidence for down-regulation of phosphoinositide 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR)-dependent translation regulatory signaling pathways in Ames dwarf mice, J. Gerontol. A Biol. Sci. Med. Sci., 60, 293, 10.1093/gerona/60.3.293 · DOI · Paper page
  146. Shen, 2018, Ragulator and SLC38A9 activate the Rag GTPases through noncanonical GEF mechanisms, Proc. Natl. Acad. Sci. USA, 115, 9545, 10.1073/pnas.1811727115 · DOI
  147. Singh, 2015, 4E-BPs control fat storage by regulating the expression of Egr1 and ATGL, J. Biol. Chem., 290, 17331, 10.1074/jbc.M114.631895 · DOI
  148. Sipula, 2006, Rapamycin-mediated inhibition of mammalian target of rapamycin in skeletal muscle cells reduces glucose utilization and increases fatty acid oxidation, Metabolism, 55, 1637, 10.1016/j.metabol.2006.08.002 · DOI
  149. Škop, 2020, Mouse thermoregulation: introducing the concept of the thermoneutral point, Cell Rep., 31, 107501, 10.1016/j.celrep.2020.03.065 · DOI
  150. Stuttfeld, 2018, Architecture of the human mTORC2 core complex, eLife, 7, 10.7554/eLife.33101 · DOI
  151. Syntichaki, 2007, eIF4E function in somatic cells modulates ageing in Caenorhabditis elegans, Nature, 445, 922, 10.1038/nature05603 · DOI · Paper page
  152. Tang, 2016, Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism, Nat. Commun., 7, 11365, 10.1038/ncomms11365 · DOI
  153. Tóth, 2008, Longevity pathways converge on autophagy genes to regulate life span in Caenorhabditis elegans, Autophagy, 4, 330, 10.4161/auto.5618 · DOI
  154. Tran, 2016, Rapamycin blocks induction of the thermogenic program in white adipose tissue, Diabetes, 65, 927, 10.2337/db15-0502 · DOI
  155. Tsai, 2015, Muscle-specific 4E-BP1 signaling activation improves metabolic parameters during aging and obesity, J. Clin. Invest., 125, 2952, 10.1172/JCI77361 · DOI · Paper page
  156. Tsai, 2016, Increased 4E-BP1 expression protects against diet-induced obesity and insulin resistance in male mice, Cell Rep., 16, 1903, 10.1016/j.celrep.2016.07.029 · DOI · Paper page
  157. Urfer, 2017, A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs, GeroScience, 39, 117, 10.1007/s11357-017-9972-z · DOI · Paper page
  158. Van Nostrand, 2020, AMPK regulation of Raptor and TSC2 mediate metformin effects on transcriptional control of anabolism and inflammation, Genes Dev., 34, 1330, 10.1101/gad.339895.120 · DOI · Paper page
  159. Vander Heiden, 2017, Understanding the intersections between metabolism and cancer Biology, Cell, 168, 657, 10.1016/j.cell.2016.12.039 · DOI
  160. Vézina, 1975, Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle, J. Antibiot. (Tokyo), 28, 721, 10.7164/antibiotics.28.721 · DOI
  161. Villa, 2021, mTORC1 stimulates cell growth through SAM synthesis and m(6)A mRNA-dependent control of protein synthesis, Mol. Cell, 81, 2076, 10.1016/j.molcel.2021.03.009 · DOI
  162. Viscarra, 2020, Histone demethylase JMJD1C is phosphorylated by mTOR to activate de novo lipogenesis, Nat. Commun., 11, 796, 10.1038/s41467-020-14617-1 · DOI
  163. Wang, 2017, Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism, Aging Cell, 16, 564, 10.1111/acel.12587 · DOI · Paper page
  164. Wang, 2015, Metabolism. Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1, Science, 347, 188, 10.1126/science.1257132 · DOI
  165. Wilkinson, 2012, Rapamycin slows aging in mice, Aging Cell, 11, 675, 10.1111/j.1474-9726.2012.00832.x · DOI · Paper page
  166. Wu, 2013, Increased mammalian lifespan and a segmental and tissue-specific slowing of aging after genetic reduction of mTOR expression, Cell Rep., 4, 913, 10.1016/j.celrep.2013.07.030 · DOI · Paper page
  167. Xiong, 2017, Arginase-II deficiency extends lifespan in mice, Front. Physiol., 8, 682, 10.3389/fphys.2017.00682 · DOI
  168. Ye, 2015, GCN2 sustains mTORC1 suppression upon amino acid deprivation by inducing Sestrin2, Genes Dev., 29, 2331, 10.1101/gad.269324.115 · DOI
  169. Yin, 2020, Raptor determines beta-cell identity and plasticity independent of hyperglycemia in mice, Nat. Commun., 11, 2538, 10.1038/s41467-020-15935-0 · DOI
  170. Yip, 2010, Structure of the human mTOR complex I and its implications for rapamycin inhibition, Mol. Cell, 38, 768, 10.1016/j.molcel.2010.05.017 · DOI · Paper page
  171. Yu, 2019, Calorie-restriction-induced insulin sensitivity is mediated by adipose mTORC2 and not required for lifespan extension, Cell Rep., 29, 236, 10.1016/j.celrep.2019.08.084 · DOI · Paper page
  172. Yu, 2011, Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling, Science, 332, 1322, 10.1126/science.1199484 · DOI
  173. Yuan, 2012, Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2, J. Biol. Chem., 287, 29579, 10.1074/jbc.M112.386854 · DOI
  174. Zaseck, 2016, Rapamycin attenuates age-associated changes in tibialis anterior tendon viscoelastic properties, J. Gerontol. A Biol. Sci. Med. Sci., 71, 858, 10.1093/gerona/glv307 · DOI
  175. Zhang, 2008, Restoration of chaperone-mediated autophagy in aging liver improves cellular maintenance and hepatic function, Nat. Med., 14, 959, 10.1038/nm.1851 · DOI · Paper page
  176. Zhang, 2017, Moderate lifelong overexpression of tuberous sclerosis complex 1 (TSC1) improves health and survival in mice, Sci. Rep., 7, 834, 10.1038/s41598-017-00970-7 · DOI · Paper page
  177. Zhang, 2017, Structural basis for Ragulator functioning as a scaffold in membrane-anchoring of Rag GTPases and mTORC1, Nat. Commun., 8, 1394, 10.1038/s41467-017-01567-4 · DOI
  178. Zhou, 2015, Dynamic visualization of mTORC1 activity in living cells, Cell Rep., 10, 1767, 10.1016/j.celrep.2015.02.031 · DOI
  179. Zhu, 2021, Monomethyl branched-chain fatty acid mediates amino acid sensing upstream of mTORC1, Dev. Cell, 56, 2692, 10.1016/j.devcel.2021.09.010 · DOI
  180. Zinzalla, 2011, Activation of mTORC2 by association with the ribosome, Cell, 144, 757, 10.1016/j.cell.2011.02.014 · DOI

Cited by

Sorted by citations

See all 174

Metadata

Authors
Simcox, J., & Lamming, D. W.
Venue
Developmental Cell
Publisher
Elsevier BV
Published
2022-03
Volume
57
Issue
6
Pages
691-706
ISSN
1534-5807
Cited by
174
References
41
Language
en
Funders
  • Department of Pathology and Laboratory Medicine, School of Medicine and Public Health, University of Wisconsin-Madison
  • National Institutes of Health (P30DK020579)
  • National Institute on Aging (AG056771, AG061635, AG062328, DK125859)
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • U.S. Department of Veterans Affairs (I01-BX004031)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12HD101368)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review